{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:11:25Z","timestamp":1783123885666,"version":"3.54.6"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009098","name":"Japanese Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resinv.2026.101412","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:30:21Z","timestamp":1777876221000},"page":"101412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The guide for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease 2025"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-5459","authenticated-orcid":false,"given":"Yasuhiro","family":"Kondoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kawahito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8636-5243","authenticated-orcid":false,"given":"Hiromi","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3187-4264","authenticated-orcid":false,"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1789-1984","authenticated-orcid":false,"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-1781","authenticated-orcid":false,"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Gono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3378-6412","authenticated-orcid":false,"given":"Tomohiro","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Johkoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-6585","authenticated-orcid":false,"given":"Masaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-988X","authenticated-orcid":false,"given":"Noboru","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-0647","authenticated-orcid":false,"given":"Ran","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1326-8343","authenticated-orcid":false,"given":"Atsuhito","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ei","family":"Sada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1573-6462","authenticated-orcid":false,"given":"Susumu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9622-6289","authenticated-orcid":false,"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0065-929X","authenticated-orcid":false,"given":"Tohru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Waseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-6087","authenticated-orcid":false,"given":"Hideaki","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-6282","authenticated-orcid":false,"given":"Hidekata","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reoto","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-6136","authenticated-orcid":false,"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101412_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.resinv.2021.04.011","article-title":"2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease","volume":"59","author":"Kondoh","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101412_bib2","series-title":"The guide for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease 2025","year":"2025"},{"key":"10.1016\/j.resinv.2026.101412_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17476348.2023.2176303","article-title":"Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements","volume":"17","author":"Kuwana","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.resinv.2026.101412_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17476348.2024.2374910","article-title":"Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis\/dermatomyositis (PM\/DM-ILD): development of expert consensus-based clinical algorithms","volume":"18","author":"Kondoh","year":"2024","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.resinv.2026.101412_bib5","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s10067-020-04973-0","article-title":"Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies","volume":"39","author":"Hamaguchi","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2026.101412_bib6","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/diagnostics13182929","article-title":"The autoantibody array assay: a novel autoantibody detection method","volume":"13","author":"Norimatsu","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.resinv.2026.101412_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.210.2.r99ja15333","article-title":"Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients","volume":"210","author":"Akira","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2026.101412_bib8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ejrad.2016.05.012","article-title":"Antisynthetase syndrome: Pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases","volume":"85","author":"Waseda","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.resinv.2026.101412_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1148\/radiology.188.2.8327704","article-title":"Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage","volume":"188","author":"Remy-Jardin","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2026.101412_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","article-title":"Rheumatoid arthritis-related lung diseases: CT findings","volume":"232","author":"Tanaka","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.resinv.2026.101412_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005382-199623000-00002","article-title":"High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis","volume":"11","author":"Ikezoe","year":"1996","journal-title":"J Thorac Imaging"},{"issue":"4","key":"10.1016\/j.resinv.2026.101412_bib12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European respiratory society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.resinv.2026.101412_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.resinv.2026.101412_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.resinv.2026.101412_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2213-2600(19)30342-X","article-title":"Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study","volume":"8","author":"Troy","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2026.101412_bib16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2026.101412_bib17","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.202105-1193ST","article-title":"Patient-centered outcomes research in interstitial lung disease: an official American thoracic Society research statement","volume":"204","author":"Aronson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101412_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/resp.13293","article-title":"Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease","author":"Suzuki","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101412_bib19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1378\/chest.13-2626","article-title":"Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review","volume":"146","author":"Winstone","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101412_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101412_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101412_bib22","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","article-title":"Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society Clinical Practice Guideline","volume":"202","author":"Jacobs","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101412_bib23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101412_bib24","article-title":"Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2026.101412_bib25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3899\/jrheum.160339","article-title":"Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease","volume":"43","author":"Kuwana","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2026.101412_bib26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3109\/s10165-012-0756-0","article-title":"Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"23","author":"Arai","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2026.101412_bib27","first-page":"1201","article-title":"American college of rheumatology (ACR)\/American college of Chest Physicians (CHEST) Guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2023","journal-title":"Arthritis Rheumatol 2024"},{"key":"10.1016\/j.resinv.2026.101412_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101412_bib29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101412_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.resinv.2026.101412_bib32","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","article-title":"Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients","volume":"57","author":"Sato","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.21583","article-title":"Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis","volume":"64","author":"Steele","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.resinv.2026.101412_bib34","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101412_bib35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II):a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2026.101412_bib36","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101412_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis:a randomized, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2026.101412_bib38","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/rheumatology\/key213","article-title":"Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease:open label, randomized, controlled trial","volume":"57","author":"Sircar","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib39","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2665-9913(21)00107-7","article-title":"Safety and efficacy of rituximab in systemic sclerosis(DESIRES):a double-blind, investigator-initiated, randomised, placebo-controlled trial","volume":"3","author":"Ebata","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.resinv.2026.101412_bib40","first-page":"3806","article-title":"Decision-Making strategy for the treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"10","author":"Yamakawa","year":"2021","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.resinv.2026.101412_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1378\/chest.130.1.22","article-title":"Quantitative analysis of fibroblastic foci in usual interstitial pneumonia","volume":"130","author":"Enomoto","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101412_bib42","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10067-023-06623-7","article-title":"Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial","volume":"42","author":"Matteson","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2026.101412_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003132","article-title":"Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study","volume":"3","author":"Hozumi","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.resinv.2026.101412_bib44","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib45","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/jcm12072586","article-title":"Interstitial lung disease and pulmonary damage in primary Sj\u00f6gren's Syndrome: a systematic review and meta-analysis","volume":"12","author":"Berardicurti","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2026.101412_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073774","article-title":"Prognostic factors in interstitial lung disease associated with primary Sj\u00f6gren's syndrome: a retrospective analysis of 33 pathologically-proven cases","volume":"8","author":"Enomoto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2026.101412_bib47","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00296-005-0092-1","article-title":"Lymphocytic alveolitis: a surprising index of poor prognosis in patients with primary Sjogren's syndrome","volume":"26","author":"Dalavanga","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.resinv.2026.101412_bib48","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.21037\/jtd.2018.03.120","article-title":"Risk factors for primary Sj\u00f6gren syndrome-associated interstitial lung disease","volume":"10","author":"Wang","year":"2018","journal-title":"Thorac Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rmed.2018.02.023","article-title":"Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sj\u00f6gren's syndrome","volume":"137","author":"Kakugawa","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2026.101412_bib50","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1038\/s41598-022-09283-w","article-title":"Blood KL-6 predicts prognosis in primary Sj\u00f6gren's syndrome-associated interstitial lung disease","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2026.101412_bib51","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/acr.25348","article-title":"American college of rheumatology (ACR)\/American college of Chest Physicians (CHEST) Guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2023","journal-title":"Arthritis Care Res (Hoboken) 2024"},{"key":"10.1016\/j.resinv.2026.101412_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren's syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chest.2020.10.011","article-title":"Consensus Guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren's","volume":"159","author":"Lee","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101412_bib54","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101412_bib55","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1136\/annrheumdis-2011-201253","article-title":"Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study","volume":"71","author":"Gunnarsson","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","article-title":"Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study","volume":"57","author":"Reiseter","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152258","article-title":"The phenotype of mixed connective tissue disease patients having associated interstitial lung disease","volume":"63","author":"Boleto","year":"2023","journal-title":"Sem Arthritis Rheum"},{"key":"10.1016\/j.resinv.2026.101412_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2213-2600(22)00359-9","article-title":"Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial","volume":"11","author":"Maher","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2026.101412_bib59","first-page":"1182","article-title":"American college of rheumatology (ACR)\/American college of Chest Physicians (CHEST) Guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2023","journal-title":"Arthritis Rheumatol 2024"},{"key":"10.1016\/j.resinv.2026.101412_bib60","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/resp.14268","article-title":"Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: a nation-wide population-based study over 10 years","volume":"27","author":"Mageau","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101412_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.42075","article-title":"Nintedanib in patients with autoimmune disease-related progressive fibrosing interstitial lung diseases: subgroup analysis of the INBUILD trial","volume":"74","author":"Matteson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2026.101412_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/ar4550","article-title":"Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"16","author":"Sada","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2026.101412_bib64","first-page":"3618","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J 2022"},{"key":"10.1016\/j.resinv.2026.101412_bib65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"38","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101412_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020293","article-title":"Lung infections in systemic rheumatic disease: focus on opportunistic infections","volume":"18","author":"Di Franco","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2026.101412_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/art.34530","article-title":"Development and validation of a risk score for serious infection in patients with rheumatoid arthritis","volume":"64","author":"Crowson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2026.101412_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2026.101412_bib70","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keq279","article-title":"Infections in polymyositis and dermatomyositis: analysis of 192 cases","volume":"49","author":"Chen","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib71","doi-asserted-by":"crossref","first-page":"48e","DOI":"10.1016\/j.semarthrit.2010.08.003","article-title":"Infectious complications in polymyositis and dermatomyositis: a series of 279 patients","volume":"41","author":"Marie","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resinv.2026.101412_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/key150","article-title":"Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample","volume":"57","author":"Ram Poudel","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2026.101412_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/acr.22575","article-title":"Burden of serious infections in adults with systemic lupus erythematosus: a national population-based study, 1996-2011","volume":"67","author":"Tektonidou","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.resinv.2026.101412_bib75","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101412_bib76","article-title":"Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis","volume":"10","author":"Sichletidis","year":"2006","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib77","doi-asserted-by":"crossref","DOI":"10.1086\/587989","article-title":"Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging infections network","volume":"46","author":"Winthrop","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib78","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101412_bib79","article-title":"Pneumocystis pneumonia under anti-tumor necrosis factor therapy (PAT) study group. Pneumocystis pneumonia associated with infliximab in Japan","volume":"357","author":"Harigai","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101412_bib80","doi-asserted-by":"crossref","DOI":"10.1186\/ar4472","article-title":"Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study","volume":"16","author":"Katsuyama","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2026.101412_bib81","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-211796","article-title":"Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib82","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","article-title":"Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population","volume":"47","author":"Takizawa","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib83","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American Society for Transplantation and cellular therapy series: #3-Prevention of Cytomegalovirus infection and disease after hematopoietic cell Transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.resinv.2026.101412_bib84","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1183\/13993003.00829-2015","article-title":"Connective tissue diseases, multimorbidity and the ageing lung","volume":"47","author":"Spagnolo","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101412_bib85","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/BOR.0000000000000117","article-title":"Evaluation and management of gastrointestinal manifestations in scleroderma","volume":"26","author":"Kirby","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.resinv.2026.101412_bib86","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/rheumatology\/kead023","article-title":"Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis","volume":"62","author":"Kreuter","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2026.101412_bib87","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2036.2009.04190.x","article-title":"Review article: the gastrointestinal complications of myositis","volume":"31","author":"Ebert","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.resinv.2026.101412_bib88","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: an international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101412_bib89","author":"Camus"},{"key":"10.1016\/j.resinv.2026.101412_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.resinv.2017.01.002","article-title":"Consensus statement for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]","volume":"55","author":"Tokuda","year":"2017","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101412_bib91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2169\/internalmedicine.1410-22","article-title":"Early initiation of plasma exchange therapy for Anti-MDA5+ dermatomyositis with refractory rapidly progressive interstitial lung disease","volume":"63","author":"Sasaki","year":"2024","journal-title":"Intern Med"},{"issue":"23","key":"10.1016\/j.resinv.2026.101412_bib92","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2026.101412_bib93","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2169\/internalmedicine.49.3491","article-title":"Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia","volume":"49","author":"Tomii","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2026.101412_bib94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1843.2011.02051.x","article-title":"Potential benefits of early continuous positive pressure ventilation in patients with rapidly progressive interstitial pneumonia","volume":"17","author":"Yokoyama","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101412_bib95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21037\/jtd.2018.12.114","article-title":"Respiratory management of acute exacerbation of interstitial pneumonia using high-flow nasal cannula oxygen therapy: a single center cohort study","volume":"11","author":"Ito","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.resinv.2026.101412_bib96","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.chest.2018.01.006","article-title":"Outcomes and mortality prediction model of critically ill adults with acute respiratory failure and interstitial lung disease","volume":"153","author":"Gannon","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101412_bib97","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202306-1066ST","article-title":"Pulmonary rehabilitation for adults with chronic respiratory disease:an official American thoracic society clinical practice guideline","volume":"208","author":"Rochester","year":"2023","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:00:14Z","timestamp":1778850014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2212534526000468"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101412","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The guide for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease 2025","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101412"}}